498 related articles for article (PubMed ID: 25042981)
1. Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.
Burton OT; Logsdon SL; Zhou JS; Medina-Tamayo J; Abdel-Gadir A; Noval Rivas M; Koleoglou KJ; Chatila TA; Schneider LC; Rachid R; Umetsu DT; Oettgen HC
J Allergy Clin Immunol; 2014 Dec; 134(6):1310-1317.e6. PubMed ID: 25042981
[TBL] [Abstract][Full Text] [Related]
2. Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance.
Burton OT; Tamayo JM; Stranks AJ; Koleoglou KJ; Oettgen HC
J Allergy Clin Immunol; 2018 Jan; 141(1):189-201.e3. PubMed ID: 28479335
[TBL] [Abstract][Full Text] [Related]
3. Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness.
Orgel K; Burk C; Smeekens J; Suber J; Hardy L; Guo R; Burks AW; Kulis M
Clin Exp Allergy; 2019 Apr; 49(4):461-470. PubMed ID: 30383313
[TBL] [Abstract][Full Text] [Related]
4. IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy.
Kanagaratham C; El Ansari YS; Lewis OL; Oettgen HC
Front Immunol; 2020; 11():603050. PubMed ID: 33362785
[TBL] [Abstract][Full Text] [Related]
5. Allergen-Specific IgA Antibodies Block IgE-Mediated Activation of Mast Cells and Basophils.
El Ansari YS; Kanagaratham C; Burton OT; Santos JV; Hollister BA; Lewis OL; Renz H; Oettgen HC
Front Immunol; 2022; 13():881655. PubMed ID: 35865546
[TBL] [Abstract][Full Text] [Related]
6. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG
J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing IgG
Keswani T; LaHood NA; Marini-Rapoport O; Karmakar B; Andrieux L; Reese B; Sneed SL; Pedersen LC; Mueller GA; Patil SU
J Allergy Clin Immunol; 2024 Jun; 153(6):1611-1620.e7. PubMed ID: 38460677
[TBL] [Abstract][Full Text] [Related]
8. Epicutaneously sensitized food-induced anaphylaxis is ameliorated with "oral tolerance" to antigen.
Mori Y; Ugajin T; Okada K; Handa Y; Umemoto N; Iijima H; Igawa K; Yokozeki H
Exp Dermatol; 2021 Mar; 30(3):367-376. PubMed ID: 33063903
[TBL] [Abstract][Full Text] [Related]
9. Changes in passively-sensitized basophil activation to αS1-casein after oral immunotherapy.
Matsui T; Naito M; Tagami K; Tajima I; Teshigawara M; Makino A; Kitamura K; Takasato Y; Sugiura S; Yamada C; Izumi H; Tsuge I; Kondo Y; Ito K
Immun Inflamm Dis; 2020 Jun; 8(2):188-197. PubMed ID: 32125071
[TBL] [Abstract][Full Text] [Related]
10. Allergen-specific oral immunotherapy for peanut allergy.
Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
[TBL] [Abstract][Full Text] [Related]
11. Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE.
Tsai M; Mukai K; Chinthrajah RS; Nadeau KC; Galli SJ
J Allergy Clin Immunol; 2020 Mar; 145(3):885-896.e6. PubMed ID: 31805311
[TBL] [Abstract][Full Text] [Related]
12. Rapid desensitization of mice with anti-FcγRIIb/FcγRIII mAb safely prevents IgG-mediated anaphylaxis.
Khodoun MV; Kucuk ZY; Strait RT; Krishnamurthy D; Janek K; Clay CD; Morris SC; Finkelman FD
J Allergy Clin Immunol; 2013 Dec; 132(6):1375-87. PubMed ID: 24139828
[TBL] [Abstract][Full Text] [Related]
13. Specific antibodies in oral immunotherapy for cow's milk allergy: kinetics and prediction of clinical outcome.
Savilahti EM; Kuitunen M; Savilahti E; Mäkelä MJ
Int Arch Allergy Immunol; 2014; 164(1):32-9. PubMed ID: 24853260
[TBL] [Abstract][Full Text] [Related]
14. Tissue-Specific Expression of the Low-Affinity IgG Receptor, FcγRIIb, on Human Mast Cells.
Burton OT; Epp A; Fanny ME; Miller SJ; Stranks AJ; Teague JE; Clark RA; van de Rijn M; Oettgen HC
Front Immunol; 2018; 9():1244. PubMed ID: 29928276
[TBL] [Abstract][Full Text] [Related]
15. Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis.
Bartnikas LM; Gurish MF; Burton OT; Leisten S; Janssen E; Oettgen HC; Beaupré J; Lewis CN; Austen KF; Schulte S; Hornick JL; Geha RS; Oyoshi MK
J Allergy Clin Immunol; 2013 Feb; 131(2):451-60.e1-6. PubMed ID: 23374269
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and immune regulation with peanut oral immunotherapy.
Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; Henry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW
J Allergy Clin Immunol; 2009 Aug; 124(2):292-300, 300.e1-97. PubMed ID: 19577283
[TBL] [Abstract][Full Text] [Related]
17. Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy.
Fox EM; Torrero MN; Evans H; Mitre E
J Allergy Clin Immunol; 2015 May; 135(5):1341-51.e1-7. PubMed ID: 25282017
[TBL] [Abstract][Full Text] [Related]
18. IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens.
Santos AF; James LK; Bahnson HT; Shamji MH; Couto-Francisco NC; Islam S; Houghton S; Clark AT; Stephens A; Turcanu V; Durham SR; Gould HJ; Lack G
J Allergy Clin Immunol; 2015 May; 135(5):1249-56. PubMed ID: 25670011
[TBL] [Abstract][Full Text] [Related]
19. Allergen-specific immunosuppression by ovalbumin fused with diphtheria toxin in mice sensitized with albumins of different origin.
Lee BK; Yoo JE; Jang YS; Kim JY; Hong CS; Ro JY
Clin Exp Allergy; 2004 Oct; 34(10):1642-8. PubMed ID: 15479282
[TBL] [Abstract][Full Text] [Related]
20. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children.
Thyagarajan A; Jones SM; Calatroni A; Pons L; Kulis M; Woo CS; Kamalakannan M; Vickery BP; Scurlock AM; Wesley Burks A; Shreffler WG
Clin Exp Allergy; 2012 Aug; 42(8):1197-205. PubMed ID: 22805467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
